296 results
Page 5 of 15
8-K
EX-99.1
kv2ax79khszx l2p08pp
26 Mar 20
Cassava Sciences Announces Full-year 2019 Financial Results and Anticipated Key Milestones for 2020
8:17am
8-K
EX-99.1
qrwx ubgfg6g8mwmkc
6 Dec 19
Regulation FD Disclosure
4:40pm
8-K
EX-99.1
rpyhmp4du1bk c1hw6g
9 Sep 19
Cassava Sciences Reports Positive Phase 2a Clinical Results in Alzheimer’s Patients
7:45am
8-K
34gmn lvreyxi0fs
9 May 19
Submission of Matters to a Vote of Security Holders
4:22pm
8-K
EX-3.1
lrkhv03 rx
27 Mar 19
Pain Therapeutics Announces Name Change to
3:02pm
8-K
EX-99.1
uh90v
8 Feb 19
Pain Therapeutics Announces Feedback from
4:04pm